1. Home
  2. BPRN vs ACIU Comparison

BPRN vs ACIU Comparison

Compare BPRN & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Princeton Bancorp Inc. (PA)

BPRN

Princeton Bancorp Inc. (PA)

HOLD

Current Price

$37.53

Market Cap

238.5M

Sector

Finance

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.37

Market Cap

235.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BPRN
ACIU
Founded
2007
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.5M
235.1M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
BPRN
ACIU
Price
$37.53
$2.37
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
6.6K
285.1K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
3.93%
N/A
EPS Growth
74.84
N/A
EPS
0.91
N/A
Revenue
N/A
N/A
Revenue This Year
$9.96
$706.75
Revenue Next Year
$6.13
$321.13
P/E Ratio
$41.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.21
$1.65
52 Week High
$37.99
$4.00

Technical Indicators

Market Signals
Indicator
BPRN
ACIU
Relative Strength Index (RSI) 67.96 41.80
Support Level $33.78 $2.03
Resistance Level N/A $3.92
Average True Range (ATR) 0.46 0.15
MACD 0.28 -0.00
Stochastic Oscillator 98.23 31.69

Price Performance

Historical Comparison
BPRN
ACIU

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a full-service financial institution providing personal and business banking services, including checking and savings accounts, as well as a range of lending products such as residential, commercial, construction, and consumer loans, including home equity loans and lines of credit. The Bank operates branches and conducts loan origination activities in areas of the New York City metropolitan area. Its loan portfolio is segmented into commercial real estate (including owner-occupied, non-owner-occupied, and multi-family properties), construction loans (mainly for residential developments), commercial and industrial loans (for business purposes), residential real estate loans (secured by one-to-four family properties), and consumer/HELOC loans.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: